BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35730597)

  • 1. Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart Disease.
    Ogasawara T; Fujii Y; Kakiuchi N; Shiozawa Y; Sakamoto R; Ogawa Y; Ootani K; Ito E; Tanaka T; Watanabe K; Yoshida Y; Kimura N; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2545-2555. PubMed ID: 35730597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas.
    Jones RB; Cohen DL
    Curr Cardiol Rep; 2023 Nov; 25(11):1451-1460. PubMed ID: 37847359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic EPAS1 Variants in Pheochromocytoma and Paraganglioma in Patients With Sickle Cell Disease.
    White G; Nonaka D; Chung TT; Oakey RJ; Izatt L
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3302-3310. PubMed ID: 37285480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype.
    Celada L; Cubiella T; San-Juan-Guardado J; Gutiérrez G; Beiguela B; Rodriguez R; Poch M; Astudillo A; Grijalba A; Sánchez-Sobrino P; Tous M; Navarro E; Serrano T; Paja M; Valdés N; Chiara MD
    J Pathol; 2023 Jan; 259(1):103-114. PubMed ID: 36314599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
    Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
    Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma.
    Ma X; Ling C; Zhao M; Wang F; Cui Y; Wen J; Ji Z; Zhang C; Chen S; Tong A; Li Y
    Front Endocrinol (Lausanne); 2022; 13():921645. PubMed ID: 35966080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.
    Jensterle M; Podbregar A; Janež A; Rakusa M; Goricar K; Prokšelj K
    Endocrine; 2022 Dec; 78(3):580-586. PubMed ID: 36194345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
    Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
    Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional significance of germline EPAS1 variants.
    Dwight T; Kim E; Bastard K; Benn DE; Eisenhofer G; Richter S; Mannelli M; Rapizzi E; Prejbisz A; Pęczkowska M; Pacak K; Clifton-Bligh R
    Endocr Relat Cancer; 2021 Feb; 28(2):97-109. PubMed ID: 33300499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.
    Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Mutations and Expressions of
    Islam F; Pillai S; Gopalan V; Lam AK
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
    Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
    Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic bases of pheochromocytoma and paraganglioma.
    Cascón A; Calsina B; Monteagudo M; Mellid S; Díaz-Talavera A; Currás-Freixes M; Robledo M
    J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36520714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal pheochromocytoma-paraganglioma in a 29-year-old woman with cyanotic congenital heart disease.
    Wcislak SM; King WS; Waller BR; Goins N; Dickson PV
    Surgery; 2019 Jan; 165(1):228-231. PubMed ID: 30340856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
    Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
    J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA.
    Gagnon N; Mansour S; Bitton Y; Bourdeau I
    Endocr Pract; 2017 Oct; 23(10):1178-1192. PubMed ID: 28704094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.